1
|
Ma C, Miao QL, Song XB, Zhao XY, Li YZ, Zou M, Tang WL, Wu SC. Paeonol potentiates colistin efficacy against K. pneumoniae by promoting membrane disruption and oxidative damage. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2024; 135:156061. [PMID: 39332100 DOI: 10.1016/j.phymed.2024.156061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 07/12/2024] [Accepted: 09/14/2024] [Indexed: 09/29/2024]
Abstract
BACKGROUND Although colistin is widely recognized as the last line of antibiotics against gram-negative bacteria, the emergence and spread of colistin resistance severely diminish its clinical efficacy and application. An alternative strategy to alleviate this crisis is to identify promising colistin adjuvants with enhanced antibacterial activity. PURPOSE In this study, the adjuvant effects of paeonol on colistin and the underlying mechanisms were investigated. METHOD Minimum Inhibitory Concentration (MIC) and checkerboard assays were used to investigate the adjuvant activity and structure-activity relationship of paeonol on the antibacterial effect of colistin in vitro. Time-dependent killing and resistance development assays were used to investigate the bactericidal effects and emergence of colistin resistance. Different fluorescent probes and competitive inhibition tests were used to investigate bacterial membrane functions and potential targets. Skin infection and peritonitis-sepsis models were used to evaluate the combined in vivo effects of colistin and paeonol in vivo. RESULT Paeonol enhanced the antibacterial effects of colistin against gram-negative bacteria, particularly Klebsiella pneumoniae. Structure-activity relationship analysis showed that the hydroxyl, 4-methoxy and ketone carbonyl side chains of the benzene ring contributed to the adjuvant effect of paeonol. Paeonol enhances the bactericidal effects of colistin and minimizes the emergence of colistin resistance. Notably, mechanistic studies demonstrated that the combination of colistin and paeonol enhances membrane disruption and oxidative damage, possibly via interactions with phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CAL). Importantly, paeonol enhanced the efficacy of colistin in both the skin and peritonitis infection models. CONCLUSION This is the first report on the adjuvant potential of paeonol in colistin to combat K. pneumoniae by promoting membrane disruption and oxidative damage via targeting membrane phospholipids. Notably, the verified target, PE, provides an additional avenue for screening new colistin adjuvants.The combination therapy of paeonol and colistin is a promising strategy for treating infections caused by gram-negative pathogens to address antibiotic resistance issues.
Collapse
Affiliation(s)
- Chao Ma
- College of Veterinary Medicine, Qingdao Agricultural University, No.700 Changcheng Road, Qingdao, Shandong 266109, China
| | - Qing-Long Miao
- College of Veterinary Medicine, Qingdao Agricultural University, No.700 Changcheng Road, Qingdao, Shandong 266109, China
| | - Xiang-Bin Song
- Shandong Provincial Key Laboratory of Quality Safety Monitoring and Risk Assessment for Animal Products, Shandong Center for Quality Control of Feed and Veterinary Drug, Jinan 250100, China
| | - Xiao-Yu Zhao
- Shandong Provincial Key Laboratory of Quality Safety Monitoring and Risk Assessment for Animal Products, Shandong Center for Quality Control of Feed and Veterinary Drug, Jinan 250100, China
| | - You-Zhi Li
- Shandong Provincial Key Laboratory of Quality Safety Monitoring and Risk Assessment for Animal Products, Shandong Center for Quality Control of Feed and Veterinary Drug, Jinan 250100, China
| | - Ming Zou
- College of Veterinary Medicine, Qingdao Agricultural University, No.700 Changcheng Road, Qingdao, Shandong 266109, China
| | - Wen-Li Tang
- Shandong Provincial Key Laboratory of Quality Safety Monitoring and Risk Assessment for Animal Products, Shandong Center for Quality Control of Feed and Veterinary Drug, Jinan 250100, China.
| | - Shuai-Cheng Wu
- College of Veterinary Medicine, Qingdao Agricultural University, No.700 Changcheng Road, Qingdao, Shandong 266109, China.
| |
Collapse
|
2
|
Souza VDOE, Taboada TB, Dos Santos Ramalho B, Pires GN, Da Costa TP, El-Cheikh MC, Carneiro K, Martinez AMB. Valproic acid ameliorates morpho-dysfunctional effects triggered by Ischiatic nerve crush injury-induced by compression model in mice: nerve regeneration and immune-modulatory pathway. Brain Res Bull 2024:111140. [PMID: 39612954 DOI: 10.1016/j.brainresbull.2024.111140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Revised: 11/20/2024] [Accepted: 11/21/2024] [Indexed: 12/01/2024]
Abstract
Peripheral nerve injuries are extremely severe and may lead to permanent disability, despite the regenerative capacity of the peripheral nervous system (PNS). To date, there is no established pharmacological therapy capable of predicting functional recovery and alleviation of trauma-related symptoms such as neuropathic pain, inflammation and weakness, which are the main targets for current therapies. In this work we provide new evidence for a therapeutic use of valproic acid (VPA) upon ischiatic nerve injury. Ischiatic nerve-injured mice treated with VPA after lesion, displayed an improvement in pain and motor function associated with an increase in the number of myelinated nerve fibers, and exhibited a more organized microenvironment during regeneration. In addition, VPA treatment also promoted an immunomodulatory capacity, leading to a significant enhancement of neutrophils in the peritoneal cavity, suggesting its role on the sensory and motor recovery after ischiatic nerve injury. This highlights the physiological role of VPA during ischiatic nerve regeneration and contributes to the characterization of innovative pharmacological epigenetic therapy capable of accelerating peripheral nerve regeneration with critical impacts on the clinical practice.
Collapse
Affiliation(s)
- Viviane de Oliveira E Souza
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Neurodegeneração e Reparo, Faculdade de Medicina, Universidade Federal do Rio de Janeiro
| | - Tiago Bastos Taboada
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro
| | - Bruna Dos Santos Ramalho
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro
| | - Greice Nascimento Pires
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro
| | - Thayse Pinheiro Da Costa
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Neurodegeneração e Reparo, Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Proliferação e Diferenciação Celular, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro
| | - Marcia Cury El-Cheikh
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Proliferação e Diferenciação Celular, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro
| | - Katia Carneiro
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Proliferação e Diferenciação Celular, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro
| | - Ana Maria Blanco Martinez
- Programa de Pós-graduação em Medicina (Anatomia Patológica), Faculdade de Medicina, Universidade Federal do Rio de Janeiro; Laboratório de Neurodegeneração e Reparo, Faculdade de Medicina, Universidade Federal do Rio de Janeiro.
| |
Collapse
|
3
|
Cao X, Zhang Y, Shi Y, Li Y, Gao L, Wang X, Sun L. Identification of critical mitochondrial hub gene for facial nerve regeneration. Biochem Cell Biol 2024; 102:179-193. [PMID: 38086039 DOI: 10.1139/bcb-2023-0224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2024] Open
Abstract
Mitochondria play a critical role in nerve regeneration, yet the impact of gene expression changes related to mitochondria in facial nerve regeneration remains unknown. To address this knowledge gap, we analyzed the expression profile of the facial motor nucleus (FMN) using data obtained from the Gene Expression Omnibus (GEO) database (GSE162977). By comparing different time points in the data, we identified differentially expressed genes (DEGs). Additionally, we collected mitochondria-related genes from the Gene Ontology (GO) database and intersected them with the DEGs, resulting in the identification of mitochondria-related DEGs (MIT-DEGs). To gain further insights, we performed functional enrichment and pathway analysis of the MIT-DEGs. To explore the interactions among these MIT-DEGs, we constructed a protein-protein interaction (PPI) network using the STRING database and identified hub genes using the Degree algorithm of Cytoscape software. To validate the relevance of these genes to nerve regeneration, we established a rat facial nerve injury (FNI) model and conducted a series of experiments. Through these experiments, we confirmed three MIT-DEGs (Myc, Lyn, and Cdk1) associated with facial nerve regeneration. Our findings provide valuable insights into the transcriptional changes of mitochondria-related genes in the FMN following FNI, which can contribute to the development of new treatment strategies for FNI.
Collapse
Affiliation(s)
- Xiaofang Cao
- Department of Dentistry, The Second Affiliated Hospital, Harbin Medical University, Harbin, China
- Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, Harbin Medical University, Harbin, China
| | - Yan Zhang
- Department of Dentistry, The Second Affiliated Hospital, Harbin Medical University, Harbin, China
| | - Yu Shi
- Department of Dentistry, The Second Affiliated Hospital, Harbin Medical University, Harbin, China
| | - Ying Li
- Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, Harbin Medical University, Harbin, China
- Heilongjiang Academy of Medical Sciences, Harbin, China
| | - Li Gao
- Department of Dentistry, The Second Affiliated Hospital, Harbin Medical University, Harbin, China
| | - Xiumei Wang
- Department of Dentistry, The Second Affiliated Hospital, Harbin Medical University, Harbin, China
| | - Liang Sun
- Department of Human Anatomy, School of Basic Medicine, Harbin Medical University, Harbin, China
| |
Collapse
|
4
|
The role of PI3K/Akt signalling pathway in spinal cord injury. Biomed Pharmacother 2022; 156:113881. [DOI: 10.1016/j.biopha.2022.113881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Revised: 10/13/2022] [Accepted: 10/13/2022] [Indexed: 11/18/2022] Open
|
5
|
Valproic Acid: A Potential Therapeutic for Spinal Cord Injury. Cell Mol Neurobiol 2020; 41:1441-1452. [DOI: 10.1007/s10571-020-00929-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 07/20/2020] [Indexed: 02/06/2023]
|
6
|
Li L, Cai J, Yuan Y, Mao Y, Xu L, Han Y, Li J, Wang H. Platelet-rich plasma can release nutrient factors to promote facial nerve crush injury recovery in rats. Saudi Med J 2019; 40:1209-1217. [PMID: 31828272 PMCID: PMC6969627 DOI: 10.15537/smj.2019.12.24747] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Accepted: 11/11/2019] [Indexed: 11/16/2022] Open
Abstract
To evaluate the effects of platelet-rich plasma (PRP) on promoting neural repair after facial nerve compression in rats and the mechanism by which this occurs. Methods: Adult Wistar rats (n=100) were divided into 3 groups: healthy controls, surgery-only, and surgery+PRP groups. The rats underwent nerve crush injury to establish a facial palsy model. The blood from the rats was used to prepare the PRP for application to the injury site. The evaluation methods included vibrissae movement, eyelid closure, and electrophysiology. Electron microscopy, immunohistochemistry, and real-time polymerase chain reaction (PCR) were used to detect nutrient factor expression in the brain and nerve sections. This study was conducted in Shandong Provincial ENT Hospital Affiliated to Shandong University, Shandong, China between January and November 2018. Results: Platelet-rich plasma promotes the recovery of vibrissae movement, eyelid closure, and electrophysiological function in a rat model of nerve crush injury. Hematoxylin and eosin staining, toluidine blue staining, and electron microscopy showed significant recovery of Schwann cells and axons in the PRP group. Polymerase chain reaction results showed that PRP releases growth factors, which include nerve growth factor and brain-derived neurotrophic factor. Immunohistochemistry also demonstrated higher levels of S-100 protein expression in the PRP group compared to the other groups. Conclusions: Platelet-rich plasma releases nutrient factors in the brainstem, and the use of PRP can promote injury recovery.
Collapse
Affiliation(s)
- Liheng Li
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital Affiliated to Shandong University, Jinan, People Republic of China. E-mail.
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Zhou S, Wu M, Chen G, Tremp M, Kalbermatten D, Wang W, Wang W. Effects of repeated transection and coaptation of peripheral nerves on axonal regeneration and motoneuron survival. J Plast Reconstr Aesthet Surg 2019; 72:1326-1333. [PMID: 31085126 DOI: 10.1016/j.bjps.2019.03.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2018] [Revised: 01/26/2019] [Accepted: 03/24/2019] [Indexed: 11/19/2022]
Abstract
BACKGROUND AND PURPOSE Salvage procedures for facial reanimation can involve a second neurorrhaphy operation. It remains unclear whether reuse of the original donor nerve in the salvage procedure remains likely to produce successful outcome. This study aimed to investigate the effect of repeated transection and coaptation of a nerve on axonal regrowth and motoneuron survival. MATERIALS AND METHODS The sciatic nerves of Sprague Dawley rats were transected and microsutured once (the one-time group) or repeatedly at eight-week intervals (the repeated group), and the animals remained alive for eight weeks before sacrifice. The gastrocnemius muscle was weighed, and muscle fiber diameter was measured with hematoxylin-eosin staining. Axonal count of the distal nerve stump was calculated by toluidine blue staining. Myelin thickness and axonal diameter were analyzed by transmission electronic microscopy. Finally, motoneurons were retrogradely traced to the spinal cord using Fluoro-Gold. RESULTS Repeated coaptation of nerves resulted in significant decreases of the wet weight ratio of gastrocnemius and muscle fiber diameter. The axonal counts and myelin thicknesses of the distal stumps were comparable between the groups, whereas axonal diameter was significantly smaller after repeated injury. Additionally, retrograde tracing demonstrated significantly less motoneurons in the L4-L6 spinal segments of the repeatedly injured animals than that of the one-time group. CONCLUSIONS Compared with one-time nerve injury, repetitive transection and coaptation of nerves resulted in compromised axonal regeneration, motoneuron survival, and target muscle recovery. It is possible that the final functional outcome could also be compromised, and the patients should be counseled accordingly.
Collapse
Affiliation(s)
- Sizheng Zhou
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, NO. 639, Zhizaoju Road, Shanghai 200011, China
| | - Min Wu
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, NO. 639, Zhizaoju Road, Shanghai 200011, China
| | - Gang Chen
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, NO. 639, Zhizaoju Road, Shanghai 200011, China
| | - Mathias Tremp
- Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
| | - Daniel Kalbermatten
- Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
| | - Wei Wang
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, NO. 639, Zhizaoju Road, Shanghai 200011, China.
| | - Wenjin Wang
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, NO. 639, Zhizaoju Road, Shanghai 200011, China.
| |
Collapse
|
8
|
Wu H, Ding J, Wang L, Lin J, Li S, Xiang G, Jiang L, Xu H, Gao W, Zhou K. Valproic acid enhances the viability of random pattern skin flaps: involvement of enhancing angiogenesis and inhibiting oxidative stress and apoptosis. DRUG DESIGN DEVELOPMENT AND THERAPY 2018; 12:3951-3960. [PMID: 30510403 PMCID: PMC6248271 DOI: 10.2147/dddt.s186222] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Background Random skin flaps are commonly applied during plastic surgery, but distal flap necrosis limits their clinical applications. Valproic acid (VPA), a histone deacetylase inhibitor and a traditional antiepileptic agent, may promote flap survival. Materials and methods Sprague–Dawley rats were randomly divided into VPA-treated and control groups. All rats received VPA or saline by intraperitoneal injections once daily for 7 days after the modified McFarlane flap model was established. On postoperative day 7, flap survival, laser Doppler blood flow, and water content were examined for flap viability, hematoxylin and eosin staining (H&E), immunohistochemistry (IHC), and Western blot analysis, and the status of angiogenesis, apoptosis, and oxidative stress were detected in the ischemic flaps. Results VPA increased the survival area, blood flow, and number of microvessels in skin flaps on postoperative day 7 and reduced edema. VPA promoted angiogenesis by enhancing vascular endothelial growth factor (VEGF) mRNA transcription and upregulating VEGF and cadherin 5 expression, inhibited apoptosis via reduction of caspase 3 cleavage, and relieved oxidative stress by increasing superoxide dismutase (SOD) and glutathione (GSH) levels and reducing the malondialdehyde (MDA) level. Conclusion VPA promoted random skin flap survival by enhancing angiogenesis and inhibiting oxidative stress and apoptosis.
Collapse
Affiliation(s)
- Hongqiang Wu
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Jian Ding
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Lei Wang
- The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Jinti Lin
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Shihen Li
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Guangheng Xiang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Liangfu Jiang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Huazi Xu
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Weiyang Gao
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| | - Kailiang Zhou
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China, ; .,Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China, ; .,The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China, ;
| |
Collapse
|